- Previous Rank61
- Revenue 3 Yr Annual Growth Rate27%
- Revenue 3 Yr Growth Rank57
- EPS 3 Yr Annual Growth Rate127%
- EPS 3 Yr Growth Rank9
- Total Return 3 Yr Annual Rate72%
- Total Return 3 Yr Rank4
More use of its top device, Impella 2.5, gives this producer of small heart pumps a healthy pulse. Its latest quarterly sales jumped 40% vs. the same period in 2015.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Information
| Location | Danvers, Mass. |
| Industry | Medical Products & Equipment |
| Sector | Health Care |
| Current Streak | 2 |
| Years on List | 2 |
| CEO | Michael Minogue |
| Website | http://www.abiomed.com |
Revenue and net income for the four quarters ended on or before April 30, 2016.!Total return for the period ended June 30, 2016.
Revenue, Net Income
| Revenue Past Four Quarters ($M) | $330 |
| Net Income Past Four Quarters ($M) | $38 |
Growth Rates and Ranks
| Revenue 3 Yr Growth Rank | 57 |
| EPS 3 Yr Annual Growth Rate | 127% |
| EPS 3 Yr Growth Rank | 9 |
| Total Return 3 Yr Annual Rate | 72% |
| Total Return 3 Yr Rank | 4 |
